Request Sample Inquiry
Cancer Stem Cells Market

Cancer Stem Cells Market

Cancer Stem Cells Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

280

Base Year:

2023

Date

Jun - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2508

Segments Covered
  • By Type By Type Breast, Bladder, Blood, Lung, Brain, Colorectal, Pancreatic, Liver
  • By Application By Application Stem Cell-based Cancer Therapy, Targeted Cancerous Stem Cells
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 1.34 Billion
Revenue 2032Revenue 2032: USD 3.72 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 12%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Cancer Stem Cells Market - Segment Analysis
    1. Overview
    2. Global Cancer Stem Cells Market, 2016 - 2028 (USD Million)
    3. Global Cancer Stem Cells Market - by Type
      1. By Breast
      2. By Bladder
      3. By Blood
      4. By Lung
      5. By Brain
      6. By Colorectal
      7. By Pancreatic
      8. By Liver
    4. Global Cancer Stem Cells Market - by Application
      1. By Stem Cell-based Cancer Therapy
      2. By Targeted Cancerous Stem Cells
    5. Global Cancer Stem Cells Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Cancer Stem Cells Market - Segment Analysis
    1. Overview
    2. North America Cancer Stem Cells Market, 2016 - 2028 (USD Million)
    3. North America Cancer Stem Cells Market, by Type
      1. By Breast
      2. By Bladder
      3. By Blood
      4. By Lung
      5. By Brain
      6. By Colorectal
      7. By Pancreatic
      8. By Liver
    4. North America Cancer Stem Cells Market, by Application
      1. By Stem Cell-based Cancer Therapy
      2. By Targeted Cancerous Stem Cells
    5. North America Cancer Stem Cells Market, by Country
      1. U.S.
        1. U.S. Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. U.S. Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      2. Canada
        1. Canada Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Canada Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      3. Mexico
        1. Mexico Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Mexico Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
  5. Europe Cancer Stem Cells Market - Segment Analysis
    1. Overview
    2. Europe Cancer Stem Cells Market, 2016 - 2028 (USD Million)
    3. Europe Cancer Stem Cells Market, by Type
      1. By Breast
      2. By Bladder
      3. By Blood
      4. By Lung
      5. By Brain
      6. By Colorectal
      7. By Pancreatic
      8. By Liver
    4. Europe Cancer Stem Cells Market, by Application
      1. By Stem Cell-based Cancer Therapy
      2. By Targeted Cancerous Stem Cells
    5. Europe Cancer Stem Cells Market, by Country
      1. Germany
        1. Germany Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Germany Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      2. UK
        1. UK Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. UK Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      3. France
        1. France Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. France Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      4. Spain
        1. Spain Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Spain Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      5. Italy
        1. Italy Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Italy Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      6. BENELUX
        1. BENELUX Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. BENELUX Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      7. Rest of Europe
        1. Rest Of Europe Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Rest Of Europe Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
  6. Asia Pacific Cancer Stem Cells Market - Segment Analysis
    1. Overview
    2. Asia Pacific Cancer Stem Cells Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Cancer Stem Cells Market, by Type
      1. By Breast
      2. By Bladder
      3. By Blood
      4. By Lung
      5. By Brain
      6. By Colorectal
      7. By Pancreatic
      8. By Liver
    4. Asia Pacific Cancer Stem Cells Market, by Application
      1. By Stem Cell-based Cancer Therapy
      2. By Targeted Cancerous Stem Cells
    5. Asia Pacific Cancer Stem Cells Market, by Country
      1. China
        1. China Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. China Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      2. Japan
        1. Japan Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Japan Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      3. India
        1. India Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. India Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      4. South Korea
        1. South Korea Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. South Korea Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      5. South East Asia
        1. South East Asia Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. South East Asia Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Rest of Asia Pacific Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
  7. Latin America Cancer Stem Cells Market - Segment Analysis
    1. Overview
    2. Latin America Cancer Stem Cells Market, 2016 - 2028 (USD Million)
    3. Latin America Cancer Stem Cells Market, by Type
      1. By Breast
      2. By Bladder
      3. By Blood
      4. By Lung
      5. By Brain
      6. By Colorectal
      7. By Pancreatic
      8. By Liver
    4. Latin America Cancer Stem Cells Market, by Application
      1. By Stem Cell-based Cancer Therapy
      2. By Targeted Cancerous Stem Cells
    5. Latin America Cancer Stem Cells Market, by Country
      1. Brazil
        1. Brazil Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Brazil Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      2. Argentina
        1. Argentina Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Argentina Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      3. Rest of Latin America
        1. Rest of Latin America Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Rest of Latin America Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
  8. Middle East & Africa Cancer Stem Cells Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Cancer Stem Cells Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Cancer Stem Cells Market, by Type
      1. By Breast
      2. By Bladder
      3. By Blood
      4. By Lung
      5. By Brain
      6. By Colorectal
      7. By Pancreatic
      8. By Liver
    4. Middle East & Africa Cancer Stem Cells Market, by Application
      1. By Stem Cell-based Cancer Therapy
      2. By Targeted Cancerous Stem Cells
    5. Middle East & Africa Cancer Stem Cells Market, by Country
      1. GCC Countries
        1. GCC Countries Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. GCC Countries Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      2. South Africa
        1. South Africa Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. South Africa Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Cancer Stem Cells Market, By Type
          1. By Breast
          2. By Bladder
          3. By Blood
          4. By Lung
          5. By Brain
          6. By Colorectal
          7. By Pancreatic
          8. By Liver
        2. Rest of Middle East & Africa Cancer Stem Cells Market, By Application
          1. By Stem Cell-based Cancer Therapy
          2. By Targeted Cancerous Stem Cells
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Merck KGaA (Germany)
    2. FUJIFILM Irvine Scientific Inc. (U.S.)
    3. Thermo Fisher Scientific Inc. (U.S.)
    4. STEMCELL Technologies (Canada)
    5. AbbVie Inc. (U.S.)
    6. Bionomics Inc. (Australia)
    7. MacroGenics (U.S.)
    8. Miltenyi Biotec (Germany)
    9. Sino Biological (China)
    10. Lineage Cell Therapeutics (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 01-Jul-2024
STEMCELL Technologies Receives FDA De Novo Classification for EasySep™ CD138 Positive Selection Kit
FAQ
Frequently Asked Question

  • The global Cancer Stem Cells valued at USD 1.34 Billion in 2023 and is expected to reach USD 3.72 Billion in 2032 growing at a CAGR of 12%.

  • The prominent players in the market are Merck KGaA (Germany), FUJIFILM Irvine Scientific Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), STEMCELL Technologies (Canada), AbbVie Inc. (U.S.), Bionomics Inc. (Australia), MacroGenics (U.S.), Miltenyi Biotec (Germany), Sino Biological (China), Lineage Cell Therapeutics (U.S.).

  • The market is project to grow at a CAGR of 12% between 2024 and 2032.

  • The driving factors of the Cancer Stem Cells include

  • North America was the leading regional segment of the Cancer Stem Cells in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy